We are live on ! Find out more
SVRA icon

Savara

78 hedge funds and large institutions have $92.7M invested in Savara in 2019 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 19 increasing their positions, 18 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 22

13.54% more ownership

Funds ownership: 36.85% → 50.39% (+14%)

4% more funds holding

Funds holding: 75 → 78 (+3)

6% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 18

0% more capital inflows, than outflows

Capital inflows: $13.3M | Capital outflows: $13.2M

35% less call options, than puts

Call options by funds: $146K | Put options by funds: $224K

Holders
78
Holders Change
+3
Holders Change %
+4%
% of All Funds
1.53%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
25
Increased
19
Reduced
18
Closed
22
Calls
$146​K
Puts
$224​K
Net Calls
-⁠$78​K
Net Calls Change
-⁠$96​K

SVRA Hedge Fund Activity: Q4 2019 in Review

78 of the 5,095 institutional investors tracked by Wall St. Rank reported a position in Savara (SVRA) for Q4 2019, worth a combined $92.7M — up 130% from $40.2M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new SVRA positions and 22 closed out — a net gain of 3 holders — while 19 added to existing stakes and 18 trimmed.

The largest buyer was Bain Capital Life Sciences Investors, opening a new position worth an estimated $6.17M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $4.16M sold.

  • 78 institutional investors held Savara (SVRA) as of Q4 2019, up from 75 in Q3 2019.
  • Funds reported $92.7M of Savara stock for Q4 2019, up 130% quarter-over-quarter.
  • 25 funds opened new Savara positions in Q4 2019 and 22 closed out, a net change of +3 holders.
  • The largest Savara buyer in Q4 2019 was Bain Capital Life Sciences Investors, an estimated $6.17M added.
  • The largest Savara seller in Q4 2019 was Consonance Capital Management, an estimated $4.16M sold.

Based on aggregated 13F filings for Q4 2019.